Search results
Cullinan Oncology (NASDAQ:CGEM) Now Covered by Stifel Nicolaus
ETF DAILY NEWS· 12 hours agoAnalysts at Stifel Nicolaus initiated coverage on shares of Cullinan Oncology (NASDAQ:CGEM – Get Free Report) in a report released on Wednesday, Marketbeat Ratings reports. The brokerage set ...
Earnings call: AbbVie surpasses Q1 expectations, announces CEO transition By Investing.com
Investing.com· 4 days agoThe earnings call also marked a significant leadership transition, with CEO Rick Gonzalez announcing...
Lawmakers honor popular Kansas City DJ following cancer death
KCTV 5 Kansas City· 3 days agoA popular Kansas City radio DJ is gone, but memories of his laughter and spirit live on through a...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 3 days agoReplay and MD Anderson announce FDA clearance of IND application for first-in-class PRAME-targeted T-Cell Receptor Natural Killer (TCR-NK) cell therapy for hematological malignancies Phase 1/2 study in patients with relapsed/refractory AML
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Holdings Cut by Russell Investments Group Ltd.
ETF DAILY NEWS· 2 days agoRussell Investments Group Ltd. lowered its holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 84.5% during the fourth quarter, according to its most recent Form 13F filing with ...
Curis to Release First Quarter 2024 Financial Results and Hold Conference Call on May 7, 2024
Morningstar· 3 days agoCuris, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, today announced that the Company ...
Syros Pharmaceuticals (NASDAQ:SYRS) Stock Price Passes Below 50 Day Moving Average of $5.94
ETF DAILY NEWS· 1 day agoSyros Pharmaceuticals, Inc. (NASDAQ:SYRS – Get Free Report)’s stock price passed below its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $5.94 ...
Earnings call: AbbVie surpasses Q1 expectations, announces CEO transition
Investing.com· 5 days agoThe earnings call also marked a significant leadership transition, with CEO Rick Gonzalez announcing...
Brokerages Set Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Price Target at $195.08
ETF DAILY NEWS· 3 days agoShares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the thirteen ratings firms that are currently covering the ...
Aileron Therapeutics, Inc. (NASDAQ:ALRN) Major Shareholder Of Texas/Texas Am I. University Sells...
ETF DAILY NEWS· 1 day agoAileron Therapeutics, Inc. (NASDAQ:ALRN – Get Free Report) major shareholder Of Texas/Texas Am I. University sold 20,315 shares of Aileron Therapeutics stock in a transaction that occurred on ...